Clinical and Molecular Allergy (Apr 2021)

H2-antagonist in IgE-mediated type I hypersensitivity reactions: what literature says so far?

  • Matteo Borro,
  • Simone Negrini,
  • Andrew Long,
  • Sharon Chinthrajah,
  • Giuseppe Murdaca

DOI
https://doi.org/10.1186/s12948-021-00143-y
Journal volume & issue
Vol. 19, no. 1
pp. 1 – 6

Abstract

Read online

Abstract Histamine is a monoamine synthesized from the amino acid histidine that is well-known for its role in IgE-mediated anaphylaxis but has shown pleiotropic effects on the immune system, especially in order to promote inflammatory responses. H1-receptor antagonist are common drugs used in mild/moderate allergic reactions whereas H2-receptor antagonist are commonly administered in gastric ulcer but showed some properties in allergy too. The EAACI guidelines for diagnosis and treatment of anaphylactic reactions recommend their use as third-line therapy in adjunct to H1-antagonists. The purpose of this article is to produce a complete summary of findings and evidence known so far about the usefulness of H2-receptor antagonist in allergic reactons.

Keywords